Angel Porgador spends much of his time researching Receptor, Cell biology, Immunology, Natural Cytotoxicity Triggering Receptor 1 and Immune system. Angel Porgador has included themes like Cell culture, Cell, Type 1 diabetes and Pancreas in his Receptor study. His Cell biology research incorporates elements of Virology, Cancer cell, Interleukin 21, NKG2D and Interleukin 12.
His Immunotherapy, Antigen, MHC class I, Cytokine and Innate immune system study are his primary interests in Immunology. His Antigen research includes elements of Monoclonal antibody, Antigen presentation and Molecular biology. He interconnects Chinese hamster ovary cell, Insulitis, Hemagglutinin, Virus and Diabetes mellitus in the investigation of issues within Natural Cytotoxicity Triggering Receptor 1.
The scientist’s investigation covers issues in Immunology, Receptor, Immune system, Cell biology and Cancer research. Immunotherapy, CTL*, Antibody, MHC class I and Virus are the core of his Immunology study. In his study, Hemagglutinin is strongly linked to Natural Cytotoxicity Triggering Receptor 1, which falls under the umbrella field of Receptor.
In his work, Antigen presentation and T cell is strongly intertwined with Antigen, which is a subfield of Immune system. Angel Porgador usually deals with Cell biology and limits it to topics linked to Interleukin 12 and Antigen-presenting cell. His Cancer research research incorporates themes from Cancer and Transfection.
His primary areas of study are Immune system, Cancer research, Cell biology, Antigen and Receptor. His research integrates issues of Tumor necrosis factor alpha and Antibody in his study of Immune system. His Antibody study is related to the wider topic of Immunology.
The concepts of his Cell biology study are interwoven with issues in NKG2D, Ebola virus, Human leukocyte antigen and Cell membrane. Angel Porgador has included themes like Biophysics, Ex vivo, Nanowire and Tumor microenvironment in his Antigen study. His studies deal with areas such as Signal transduction and Inhibitory postsynaptic potential as well as Receptor.
Angel Porgador mostly deals with Cell biology, NKG2D, Antigen, Immune system and Receptor. His studies in Cell biology integrate themes in fields like Antigen-presenting cell, Ebola virus, NK Cell Lectin-Like Receptor Subfamily K, HEK 293 cells and Distribution. His work carried out in the field of NKG2D brings together such families of science as Human leukocyte antigen, Cytokine secretion, Degranulation and Signal transduction.
His Antigen research integrates issues from Nanoscopic scale, Biophysics, Immune activation and Cell contraction. His research investigates the connection between Receptor and topics such as Programmed cell death that intersect with issues in Cancer and Cancer research. His work is dedicated to discovering how Cancer, Antibody are connected with Cell and other disciplines.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Decidual NK cells regulate key developmental processes at the human fetal-maternal interface
Jacob Hanna;Debra Goldman-Wohl;Yaron Hamani;Inbal Avraham.
Nature Medicine (2006)
Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells
Ofer Mandelboim;Niva Lieberman;Marianna Lev;Lada Paul.
Nature (2001)
Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody.
Angel Porgador;Jonathan W Yewdell;Yuping Deng;Jack R Bennink.
Immunity (1997)
Predominant Role for Directly Transfected Dendritic Cells in Antigen Presentation to CD8+ T Cells after Gene Gun Immunization
Angel Porgador;Kari R. Irvine;Akiko Iwasaki;Brian H. Barber.
Journal of Experimental Medicine (1998)
Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1.
Roi Gazit;Raizy Gruda;Moran Elboim;Tal I Arnon.
Nature Immunology (2006)
Recognition of viral hemagglutinins by NKp44 but not by NKp30
Tal I. Arnon;Marina Lev;Gil Katz;Yehudit Chernobrov.
European Journal of Immunology (2001)
Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus.
Tal I Arnon;Hagit Achdout;Ofer Levi;Gal Markel.
Nature Immunology (2005)
Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes.
Angel Porgador;Eli Gilboa.
Journal of Experimental Medicine (1995)
Classification of current anticancer immunotherapies
Lorenzo Galluzzi;Erika Vacchelli;José Manuel Bravo-San Pedro;Aitziber Buqué.
Oncotarget (2014)
Induction of antitumor immunity using bone marrow-generated dendritic cells.
Angel Porgador;David Snyder;Eli Gilboa.
Journal of Immunology (1996)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Hebrew University of Jerusalem
Weizmann Institute of Science
Weizmann Institute of Science
Ben-Gurion University of the Negev
Heidelberg University
Ben-Gurion University of the Negev
Ben-Gurion University of the Negev
Tel Aviv University
University of Pennsylvania
University of Miami
University of Leeds
Indiana University – Purdue University Indianapolis
Central South University
City University of Hong Kong
University of British Columbia
Wageningen University & Research
Dalhousie University
University of Genoa
McGill University
Grenoble Alpes University
University of Michigan–Ann Arbor
Texas A&M University
University of Bristol
Stony Brook University
University of Colorado Boulder
University of Illinois at Urbana-Champaign